<PAGE>


                   U.S. SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549



                                 FORM 10-QSB



           QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                      SECURITIES EXCHANGE ACT OF 1934

               For the quarterly period ended:  June 30, 1999


                      Commission file number: 0-28154



                            SMLX TECHNOLOGIES, INC.
      -----------------------------------------------------------------
      (Exact name of small business issuer as specified in its Charter)



           Colorado                                       84-1337509
-------------------------------                        ------------------
(State or other jurisdiction of                        (I.R.S. Employer
incorporation or organization)                         Identification No.)



                 376 Ansin Boulevard, Hallandale, Florida 33009
          ------------------------------------------------------------
          (Address of principal executive offices, including zip code)


                              (954) 455-0110
                        ---------------------------
                        (Issuer's telephone number)


Indicate by check mark whether the Issuer (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Exchange Act during the past 12
months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the
past 90 days.

                             Yes [ X ]   No [   ]


There were 11,544,444 shares of the Registrant's Common Stock outstanding as
of June 30, 1999.

<PAGE>


                                    INDEX


Part I: Financial Information                                      Page No.

Item 1. Financial Statements:

     Unaudited Consolidated Balance Sheets - as of
     June 30, 1999................................................   3-4

     Unaudited Consolidated Statements of Operations, Six
     Months Ended June 30, 1999 and 1998 .........................     5

     Unaudited Consolidated Statement of Cash Flows, Six
     Months Ended June 30, 1999 and 1998 ..........................    6

     Notes to Consolidated Financial Statements..................     7-8

Item 2. Management's Discussion and Analysis of
        Financial Condition and Results of Operations ...........     9

Part II: Other Information.......................................     10

     Item 1.  Legal Proceedings..................................     10

     Item 2.  Change in Securities...............................     10

     Item 3.  Defaults Upon Senior Securities....................     10

     Item 4.  Submission of Matters to a Vote
              of Security Holders................................     10

     Item 5.  Other Information..................................     10

     Item 6.  Exhibits and Reports on Form 8-K...................     10

Signatures ......................................................     10





















                                    2
<PAGE>


                   SMLX TECHNOLOGIES, INC. AND SUBSIDIARIES
                          CONSOLIDATED BALANCE SHEETS
                                 (UNAUDITED)

                                                6/30/99        12/31/98
                                               ---------       ---------
ASSETS

CURRENT ASSETS
  Cash                                         $  315,665      $   47,594
  Accounts Receivable (Net of allowance
   for uncollectible accounts of $16,733
   for 12/31/98 and 6/31/99                         5,518           2,342
  Inventory                                       143,680         141,572
  Prepaid Expenses                                 17,831          19,411
                                               ----------       ---------

    Total Current Assets                          482,694         210,919

Property, Plant and Equipment, at cost
  (Net of accumulated depreciation and
   amortization of $28,392 and $96,600
   on 6/30/99 and 12/31/98, respectively)         360,638         385,935

OTHER ASSETS

  Deposits                                          8,192           8,192
  Organization Expenses                               300           1,352
  Patents and Trademarks
   (Net of accumulated amortization of $1,307
    and $504 on 6/30/99 and 12/31/98,
    respectively)                                  65,357          58,267
  Investment in Common Stock                      200,000         200,000
                                               ----------       ---------
Total Assets                                   $1,117,181       $ 864,665
                                               ==========       =========



















THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE CONSOLIDATED FINANCIAL
STATEMENTS.

                                     3
<PAGE>



                  SMLX TECHNOLOGIES, INC. AND SUBSIDIARY
                        CONSOLIDATED BALANCE SHEETS
                                (UNAUDITED)

                                               6/30/1999        12/31/98
                                               ----------       ---------
LIABILITIES

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES
  Accounts Payable and Accrued Liabilities     $    37,144     $   160,755
  Current Portion of Notes Payable                  56,372         184,970
  Customer Deposits                                165,418         108,698
                                               -----------     -----------
    Total Current Liabilities                      258,934         454,423

LONG-TERM DEBT
  Notes Payables, Net of Current Portion           238,932         237,119
                                               -----------     -----------

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY
  Common Stock (Par Value $.0001, Authorized
   100,000,000 Shares, Issued and Outstanding
   11,544,444 Shares on 6/30/99 and 10,600,000
    on 12/31/98)                                     1,154          1,060
  Preferred Stock (Par Value $.0001, Authorized
   10,000,000 Shares, No Shares Issued and
   Outstanding)                                          -               -
  Additional Paid-In Capital                     2,481,993       1,846,084
  Deficit Accumulated                           (1,863,832)     (1,674,021)
                                               -----------     -----------
    Total Stockholders' Equity                     619,315         173,123
                                               -----------     -----------
    Total Liabilities and Stockholders'
     Equity                                    $ 1,117,181     $   864,665
                                               ===========     ===========
















THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE CONSOLIDATED FINANCIAL
STATEMENTS.

                                     4
<PAGE>



                   SMLX TECHNOLOGIES, INC. AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                                  (UNAUDITED)

                            SIX MONTHS ENDED          THREE MONTHS ENDED
                           6/30/99       6/30/98      6/30/99      6/30/98
                          ---------    ---------     ---------    ---------

REVENUES - NET            $ 406,372    $ 202,891     $ 356,221    $ 160,593

COST OF GOODS SOLD           25,506       78,638         3,502       59,281

GROSS PROFIT                380,866      124,253       352,719      101,312

OPERATING EXPENSES
 SELLING, GENERAL AND
  ADMINISTRATIVE EXPENSES   514,328      359,591       303,838      230,497
 DEPRECIATION AND
  AMORTIZATION EXPENSE       29,964       13,102        29,964        6,551
                          ---------    ---------     ---------    ---------

    TOTAL OPERATING
     EXPENSES               544,292      372,693       333,802      237,048

OPERATING INCOME (LOSS)    (163,426)    (248,440)       18,917     (135,736)

INTEREST EXPENSE            (19,953)     (21,147)       (9,076)     (10,673)
                          ---------    ---------     ---------    ---------

NET PROFIT/(LOSS)          (183,379)    (269,587)        9,841     (146,409)

NET (LOSS) PER SHARE         (0.020)      (0.030)        0.000       (0.020)

WEIGHTED AVERAGE NUMBER
 OF SHARES OUTSTANDING   11,540,000    8,000,000    11,540,000    8,500,000





















THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE CONSOLIDATED FINANCIAL
STATEMENTS.

                                       5
<PAGE>


                   SMLX TECHNOLOGIES, INC. AND SUBSIDIARIES
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                    FOR THE SIX MONTHS ENDED JUNE 30, 1999
                         AND JUNE 30, 1998 (UNAUDITED)

                                                  6/30/99       6/30/98
                                                 ----------    ---------
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net (Loss)                                     $(183,379)   $ (269,587)

  Adjustment to Reconcile Net (Loss)
   to Net Cash Provided By (Used in)
   Operating Activities:

     Depreciation and Amortization                  29,964        13,102

     Changes in Operating Assets and Liabilities:
      Accounts Receivable                           (3,176)        3,846
      Inventory                                     (2,108)       (5,971)
      Accounts Payable and Accrued Liabilities    (123,611)       (9,057)
      Customer Deposits                             56,720        (6,392)
      Prepaid Expenses and Organization Expenses     2,367       (19,561)
                                                 ---------    ----------
  Net Cash (Used In) Provided By Operating
   Activities                                     (223,223)     (293,620)
                                                 ---------    ----------

CASH FLOWS FROM INVESTING ACTIVITIES:
  Acquisition of Fixed Assets                       (3,095)      (68,409)
  Notes Payable to Stockholders                          -             -
  Patent Costs                                      (8,397)      (26,763)
                                                 ---------    ----------
  Net Cash Provided by (Used In) Investing
   Activities                                      (11,492)      (95,172)
                                                 ---------    ----------

CASH FLOWS FROM FINANCING ACTIVITIES:
  Proceeds from Private Placement                  636,003     1,000,000
  Notes Payable                                   (133,217)       89,846
                                                 ---------    ----------
Net Cash Provided By (Used In) Financing
 Activities                                        502,786     1,089,846
                                                 ---------    ----------

Net Increase (Decrease) in Cash                    268,071       701,054

Cash - Beginning of Period                          47,594        41,743
                                                 ---------    ----------
Cash - End of Period                             $ 315,665    $  742,797
                                                 =========    ==========






THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE CONSOLIDATED FINANCIAL
STATEMENTS.

                                     6
<PAGE>


                   SMLX TECHNOLOGIES, INC. AND SUBSIDIARIES
                        A DEVELOPMENT STAGE ENTERPRISE
                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                           JUNE 30, 1999 (UNAUDITED)


NOTE 1 - BASIS OF PRESENTATION

The accompanying unaudited consolidated financial statements of SMLX
Technologies, Inc. (the "Company") and its wholly-owned subsidiaries, Simplex
Medical Systems, Inc.(a Florida corporation) and Analyte Diagnostics, Inc.,
have been prepared in accordance with the instructions and requirements of
Form 10-QSB and, therefore, do not include all information and footnotes
necessary for a fair presentation of financial position, results of
operations, and cash flows in conformity with generally accepted accounting
principles.  In the opinion of management, such financial statements reflect
all adjustments (consisting only of normal recurring accruals) necessary for a
fair presentation of the results of operations and financial position for the
interim periods presented.  Operating results for the interim periods are not
necessarily indicative of the results that may be expected for the full year.
These financial statements should be read in conjunction with the Company's
annual report on Form 10-KSB.

These financial statements give effect to the March 5, 1997 reverse
acquisition whereby Music Tones Ltd. (name subsequently changed to Simplex
Medical Systems, Inc.) acquired all of the outstanding common stock of Simplex
Medical Systems, Inc. as if the transaction occurred on September 15, 1995.

NOTE 2 - basis of presentation and continued existence

The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern.  Since inception, the Company has
experienced losses aggregating $1,863,.832 and has been dependent upon loans
from stockholders and other third parties in order to satisfy operations to
date.  Management believes that funds generated from operations will provide
the Company with sufficient cash flow resources to fund the operations of the
Company.  The financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets
or the amounts and classification of liabilities that may result from the
possible inability of the Company to continue as a going concern.

NOTE 3 - INVENTORY

Inventory consists of $143,680 of finished goods as of June 30, 1999.

NOTE 4 - PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consists of the following at June 30, 1999:

       Leasehold Improvements                           $ 188,806
       Office Furniture and Equipment                      37,973
       Lab Equipment                                      260,157
                                                        ---------
       Total Equipment                                    486,936
           Less:  Accumulated Depreciation                126,299
                                                        ---------
       Total Property, Plant and Equipment              $ 360,637
                                                        =========

                                      7
<PAGE>


NOTE 5 - NOTES PAYABLE

       Interest Expense for the period ended
       June 30, 1999, amounted to:                     $  19,953

       Interest Expense for the period ended
       June 30, 1998, amounted to:                     $  21,147

NOTE 6 - INCOME TAXES

To date the Company has incurred tax operating losses and therefore has
generated no income tax liabilities.  As of June 30, 1999, the Company has
generated net operating loss carry forwards totaling $(1,863,832) which are
available to offset future taxable income, if any, through the year 2010.  As
utilization of such an operating loss for tax purposes is not assured, the
deferred tax asset has been fully reserved through the recording of 100%
valuation allowance.

The components of the net deferred tax asset are as follows at June 30, 1999:

      Deferred Tax Assets:
         Net Operating Loss Carry forward          (1,863,832)

      Valuation Allowance                          (1,863,832)


NOTE 7 - YEAR 2000 COMPLIANCE

The Company is in the process of completing a review of the effect that the
year 2000 will have on its stand alone computer system related to its ongoing
operations, its internal control systems and preparation of financial
information.  As the Company keeps both an electronic and paper backup of all
contracts, financial data and important correspondence, it does not believe
there will be any serious problem. Additionally, the Company plans to purchase
new computers for all stations that would be subject to any Y2K problems
during the third quarter of this year.

The Company has queried all vendors and suppliers of services that might have
an effect on its business and there does not appear to be any problem.



















                                    8
<PAGE>



ITEM 2.  MANAGEMENT'S DISCUSSION AND ANAYLSIS OF FINANCIAL CONDITIONS AND
RESULTS OF OPERATIONS.

     This Report contains forward-looking statements that involve a number of
risks and uncertainties.  While these statements represent the Company's
current judgement in the future direction of the business, such risks and
uncertainties could cause actual results to differ materially from any future
performance suggested herein.  Certain factors that could cause results to
differ materially from those projected in the forward-looking statements
include timing of orders and shipments, market acceptance of products, ability
to increase level of production, impact of government regulations,
availability of capital to finance growth and general economic conditions.

RESULTS OF OPERATIONS

     THREE MONTHS ENDED JUNE 30, 1999 VERSUS THREE MONTHS ENDED JUNE 30, 1998

     During the three months ended June 30, 1999, the Company had $356,221 in
revenue compared to $160,593 in revenue during the corresponding prior year
period.  The increase in revenue was due to the signing of two contracts
during April and May 1999.  Pursuant to a contract signed with Vector Medical
Technologies, Inc., the Company sold certain technologies and is to receive an
advance on royalties of $75,000 per month for four years.  Pursuant to a
contract signed with HelveStar, S.A., the Company and HelveStar formed a joint
venture named BioStar Life Sciences.  BioStar has agreed to purchase certain
non-core products from the Company for $2.4 million payable $100,000 per month
for 24 months.

     Expenses for the three months ended June 30, 1999, were approximately
$73,341 more than the corresponding prior year period.  General selling and
other administrative expenses increased due to additional personnel hired and
legal costs.

LIQUIDITY AND CAPITAL RESOURCES

     As of June 30, 1999, the Company had working capital of approximately
$223,760 compared to a deficit of approximately $(243,504) at December 31,
1998.

     The second quarter marks the first time that the Company has shown a
profit since it became operational last June.  The Company expects that the
remaining quarters of 1999 will also be profitable.

     As of June 30, 1999, the Company had no material commitments for capital
expenditures.










                                    9
<PAGE>


                           PART II.  OTHER INFORMATION

Item 1.   Legal Proceedings.

     None.

Item 2.   Changes in Securities.

     Sales of Restricted Securities.  During the quarter ended June 30, 1999,
the Company issued restricted securities as follows:

     In April 1999, the Company sold 444,444 shares of Common Stock to R&P
Venture II, an accredited investor, which is controlled by Kenneth H.
Robertson, a Director of the Company, for $200,000.

     In May 1999, the Company issued an aggregate of 125,000 shares of Common
Stock to three investors upon the conversion of convertible notes aggregating
$125,000 in principal.

     In May 1999, the Company also issued an aggregate of 375,204 shares of
Common Stock to six investors upon the exercise of options at an exercise
price of $1.58 per share, or an aggregate purchase price of $592,822.

     With respect to these sales, the Company relied on Section 4(2) of the
Act.  The investors represented that they were purchasing the shares for
investment only and not for the purpose of resale or distribution.  The
appropriate restrictive legends were placed on the certificates and stop
transfer orders were issued to the transfer agent.

Item 3.   Defaults Upon Senior Securities.

     None.

Item 4.   Submission of Matters to a Vote of Security Holders.

     None.

Item 5.   Other Information.

     None.

Item 6.   Exhibits and Reports on Form 8-K.

          (a)  Exhibit 27      Financial Data Schedule    Filed herewith
                                                          electronically

          (b)  Reports on Form 8-K.  The Company filed one Report on Form 8-K
dated May 10, 1999, reporting information under Items 5 and 7 of that form
concerning the execution of a Joint Venture Agreement with HelveStar S.A.

                                 SIGNATURES

     Pursuant to the requirements of the Securities and Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                    SMLX TECHNOLOGIES, INC.


Date:  July 16, 1999                By:/s/ Colin N. Jones
                                       Colin N. Jones, President

                                   10
<PAGE>



<PAGE>
                                EXHIBIT INDEX
EXHIBIT                                               METHOD OF FILING
-------                                        ------------------------------
  27.     Financial Data Schedule               Filed herewith electronically